BECTON DICKINSON & CO — Form 8-K
Filed July 22, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Dr. Michael Garrison, Executive Vice President and President of Medical Essentials and BioPharma Systems segments, announced retirement effective October 2, 2026, after more than 20 years with BD. A comprehensive search is underway for his Medical Essentials successor; BioPharma Systems will report directly to CEO Tom Polen. No severance terms, equity acceleration, or financial details disclosed.
Why this rating
Planned executive departure at large company; no financial impact disclosed. Routine C-suite transition; reorganization minor relative to $65.5B market cap.
See more from July 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.